Utility of RET mutant in diagnosis and treatment of melanoma

Document Type

Patent

Publication Date

11-7-2008

Abstract

The invention relates to a method of detecting a RET mutant in a melanoma cell. Also disclosed is a method of modulating the activity of a RET mutant in a melanoma cell with an agent that interferes with the activity of the RET mutant.

Area of Special Interest

Cancer

Specialty/Research Institute

Oncology

Location

United States

Comments

Patent Number: 7,943,319

Assignee

John Wayne Cancer Institute (Santa Monica, CA)

Family ID

40626214

Serial Number

12/267,541

Tech ID

07-JWCI-057

Share

COinS